Lvz, Inc. Amgen Inc Transaction History

Lvz, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $120,571 - $146,956	-534 Reduced 28.82%	1,319 $318,000
Q4 2022 Jan 17, 2023	BUY	$229.03 - $291.01 $25,651 - $32,593	112 Added 6.43%	1,853 $0
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $39,953 - $45,060	178 Added 11.39%	1,741 $392,000
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $28,838 - $32,092	125 Added 8.69%	1,563 $380,000
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $9,209 - $10,187	42 Added 3.01%	1,438 $348,000
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $30,627 - $35,050	154 Added 12.4%	1,396 $314,000
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $6,792 - $7,958	32 Added 2.64%	1,242 $264,000
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $22,890 - $25,395	98 Added 8.81%	1,210 $295,000
Q1 2021 Apr 08, 2021	BUY	$221.91 - $258.6 $12,205 - $14,223	55 Added 5.2%	1,112 $277,000
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $228,713 - $272,357	1,057 New	1,057 $243,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Lvz, Inc., based on Form 13F filings with the SEC.

Stay updated on Lvz, Inc. with notifications on news.